Bank of New York Mellon’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Sell |
51,812
-1,694
| -3% | -$14.1K | ﹤0.01% | 3573 |
|
|
2025
Q1 | $326K | Buy |
53,506
+1,378
| +3% | +$8.39K | ﹤0.01% | 3646 |
|
|
2024
Q4 | $329K | Buy |
52,128
+405
| +0.8% | +$2.56K | ﹤0.01% | 3710 |
|
|
2024
Q3 | $259K | Sell |
51,723
-17,001
| -25% | -$85K | ﹤0.01% | 3823 |
|
|
2024
Q2 | $420K | Buy |
68,724
+20,602
| +43% | +$126K | ﹤0.01% | 3665 |
|
|
2024
Q1 | $535K | Buy |
48,122
+2,129
| +5% | +$23.7K | ﹤0.01% | 3478 |
|
|
2023
Q4 | $516K | Sell |
45,993
-339
| -0.7% | -$3.8K | ﹤0.01% | 3530 |
|
|
2023
Q3 | $348K | Buy |
46,332
+1,090
| +2% | +$8.19K | ﹤0.01% | 3736 |
|
|
2023
Q2 | $399K | Buy |
+45,242
| New | +$399K | ﹤0.01% | 3702 |
|
|
2021
Q2 | – | Sell |
-44,912
| Closed | -$279K | – | 4413 |
|
|
2021
Q1 | $279K | Sell |
44,912
-954
| -2% | -$5.93K | ﹤0.01% | 3935 |
|
|
2020
Q4 | $342K | Sell |
45,866
-2,759
| -6% | -$20.6K | ﹤0.01% | 3776 |
|
|
2020
Q3 | $294K | Buy |
48,625
+186
| +0.4% | +$1.13K | ﹤0.01% | 3725 |
|
|
2020
Q2 | $404K | Buy |
+48,439
| New | +$404K | ﹤0.01% | 3578 |
|
|
2019
Q2 | – | Sell |
-22,804
| Closed | -$111K | – | 4226 |
|
|
2019
Q1 | $111K | Hold |
22,804
| – | – | ﹤0.01% | 3977 |
|
|
2018
Q4 | $145K | Buy |
22,804
+15
| +0.1% | +$95 | ﹤0.01% | 3905 |
|
|
2018
Q3 | $187K | Hold |
22,789
| – | – | ﹤0.01% | 3939 |
|
|
2018
Q2 | $237K | Buy |
+22,789
| New | +$237K | ﹤0.01% | 3882 |
|